Shanghai Fangyu Health Pharmaceutical Technology

Shanghai Fangyu Health Pharmaceutical Technology is a specialized biopharmaceutical company focused on the research, development, and industrialization of high-end inhalation preparations for respiratory diseases. Founded in 2013 and led by Dr. Jin Fang, a prominent expert in inhalation drug delivery, the company serves as the core respiratory R&D center for Joincare Pharmaceutical Group. Fangyu Health has established a robust technology platform covering various inhalation dosage forms, including metered-dose inhalers (MDIs), dry powder inhalers (DPIs), and nebulizer solutions. The company's portfolio includes several first-to-market generic inhalation drugs in China, such as fluticasone propionate and tobramycin inhalation solutions. By overcoming significant technical and regulatory barriers, Fangyu Health provides high-quality, affordable respiratory treatments for patients with asthma and COPD.